Our data show that , although vaccine formulated with a single adjuvant induced a specific antibody and cellular immune response , and reduced viral load in mice challenged with ZIKV , the combination of Alum and MPL adjuvants led to a more robust and balanced immune response , stronger neutralizing activity against three recent ZIKV human strains , and greater protection against a high - dose ZIKV challenge .